e.l.f. Beauty, Inc. (ELF) Is At $19.74 Formed Wedge; ANGES MG OSAKA ORDINARY SHARES JAPA (AMGXF) Sellers Decreased By 22.65% Their Shorts

ANGES MG INC OSAKA ORDINARY SHARES JAPA (OTCMKTS:AMGXF) had a decrease of 22.65% in short interest. AMGXF’s SI was 477,200 shares in April as released by FINRA. Its down 22.65% from 616,900 shares previously. The SI to ANGES MG INC OSAKA ORDINARY SHARES JAPA’s float is 0.65%. It closed at $5.55 lastly. It is down 0.00% since April 10, 2017 and is . It has underperformed by 11.55% the S&P500.

e.l.f. Beauty, Inc. (ELF) formed wedge down with $18.75 target or 5.00% below today’s $19.74 share price. e.l.f. Beauty, Inc. (ELF) has $922.99M valuation. The stock decreased 1.45% or $0.29 during the last trading session, reaching $19.74. About 158,357 shares traded. e.l.f. Beauty, Inc. (NYSE:ELF) has declined 26.15% since April 10, 2017 and is downtrending. It has underperformed by 37.70% the S&P500.

Analysts await e.l.f. Beauty, Inc. (NYSE:ELF) to report earnings on May, 9. They expect $0.04 earnings per share, down 20.00% or $0.01 from last year’s $0.05 per share. ELF’s profit will be $1.87 million for 123.38 P/E if the $0.04 EPS becomes a reality. After $0.21 actual earnings per share reported by e.l.f. Beauty, Inc. for the previous quarter, Wall Street now forecasts -80.95% negative EPS growth.

Among 6 analysts covering e.l.f. Beauty (NYSE:ELF), 1 have Buy rating, 1 Sell and 4 Hold. Therefore 17% are positive. e.l.f. Beauty has $34 highest and $20 lowest target. $27.33’s average target is 38.45% above currents $19.74 stock price. e.l.f. Beauty had 8 analyst reports since October 17, 2016 according to SRatingsIntel. On Monday, May 1 the stock rating was reinitiated by Piper Jaffray with “Overweight”. The firm earned “Hold” rating on Wednesday, November 1 by Stifel Nicolaus. The stock of e.l.f. Beauty, Inc. (NYSE:ELF) earned “Equal-Weight” rating by Morgan Stanley on Monday, October 17. As per Monday, October 17, the company rating was initiated by JP Morgan. The firm has “Market Perform” rating by Wells Fargo given on Monday, October 17. The stock of e.l.f. Beauty, Inc. (NYSE:ELF) has “Underweight” rating given on Friday, December 15 by JP Morgan. The firm has “Sector Weight” rating given on Thursday, December 21 by KeyBanc Capital Markets. The firm earned “Overweight” rating on Monday, October 17 by Piper Jaffray.

AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene medical products. The company has market cap of $. It offers Naglazyme, a drug for the treatment of mucopolysaccharidosis VI, an intractable disease. It currently has negative earnings. It is also developing hepatocyte growth factor plasmid, a gene therapy in the last stage of clinical development for the treatment of critical limb ischemia, which is a serious impairment of blood circulation in the legs.

e.l.f. Beauty, Inc. (NYSE:ELF) Ratings Chart